Several antiviral creams are used to treat herpes outbreaks, with the most common being acyclovir 5% cream, penciclovir 1% cream, and the over-the-counter option docosanol 10% cream (sold as Abreva). A combination cream pairing acyclovir with hydrocortisone is also available by prescription. Which one you reach for depends on whether you’re dealing with oral or genital herpes, how quickly you catch the outbreak, and whether you have access to a prescription, but the honest picture is more nuanced than any single product recommendation suggests.
The Main Prescription Creams
Acyclovir 5% cream is the most widely studied topical antiviral for herpes simplex. It works by getting absorbed into infected cells and blocking the virus from copying its DNA, which slows the outbreak. In two large randomized trials, people who applied acyclovir cream five times daily for four days had episodes lasting about half a day shorter on average than those using a placebo, and they experienced less pain during the outbreak.1PubMed Central. Acyclovir Cream for Treatment of Herpes Simplex Labialis: Results of Two Randomized, Double-Blind, Vehicle-Controlled, Multicenter Clinical Trials That might sound modest, and it is. Topical antivirals shave time off an outbreak rather than stopping one in its tracks. But for many people, even a day less of visible sores and discomfort matters.
Penciclovir 1% cream (brand name Denavir) is a close relative that also targets viral DNA replication. Head-to-head comparisons in animal models found that penciclovir cream reduced lesion area and virus levels somewhat more effectively than acyclovir cream, with penciclovir cutting lesion area by about 38% versus roughly 28% for acyclovir cream.2PubMed. Comparison of new topical treatments for herpes labialis: efficacy of penciclovir cream, acyclovir cream, and n-docosanol cream against experimental cutaneous herpes simplex virus type 1 infection In practice, the difference between the two is small enough that your choice often comes down to availability and cost. Penciclovir cream is applied every two hours while awake, which is a more demanding schedule than acyclovir’s five-times-daily regimen.
Early trials also confirmed that the cream formulation of acyclovir outperforms the older ointment version. The ointment showed antiviral effects in lab measures but struggled to produce consistent clinical improvement in patients. Once researchers switched to a modified aqueous cream base, outcomes improved, and the cream became the preferred format.3Journal of Antimicrobial Chemotherapy. Acyclovir in the management of herpes labialis If you have old tubes of acyclovir ointment, it is worth knowing it is not interchangeable with the cream.
The Over-the-Counter Option
Docosanol 10% cream, sold under the brand name Abreva, is the only FDA-approved over-the-counter antiviral cream for cold sores. Unlike acyclovir and penciclovir, docosanol does not target viral DNA directly. Instead, it works at the cell surface: it prevents the herpes virus envelope from fusing with the outer membrane of your cells, blocking the virus from getting inside in the first place.4PubMed. The anti-herpes simplex virus activity of n-docosanol includes inhibition of the viral entry process Because it acts at the entry step rather than inside already-infected cells, timing matters even more with docosanol. Applying it at the first tingle or itch gives it the best chance of keeping the virus out of cells it has not yet reached.
In the same comparative study that measured penciclovir and acyclovir cream performance, docosanol showed more limited reductions in lesion development than either prescription antiviral.2PubMed. Comparison of new topical treatments for herpes labialis: efficacy of penciclovir cream, acyclovir cream, and n-docosanol cream against experimental cutaneous herpes simplex virus type 1 infection Still, for someone who cannot get to a doctor quickly enough to obtain a prescription, docosanol is a reasonable first-line defense that you can grab at any pharmacy without a visit.
Combination Cream With Hydrocortisone
One of the more interesting developments in topical herpes treatment is a combination cream containing 5% acyclovir plus 1% hydrocortisone, marketed as Xerese in the United States. The idea is straightforward: the acyclovir fights the virus while the low-dose steroid tamps down the inflammatory response that causes much of the redness, swelling, and discomfort of an outbreak.
Clinical trial results showed that this combination reduced the frequency of ulcerative cold sore lesions and shortened healing time compared with acyclovir cream alone or placebo.5PubMed. The role of topical 5% acyclovir and 1% hydrocortisone cream Xerese in the treatment of recurrent herpes simplex labialis A separate trial found that about 42% of patients using the combination cream avoided developing an ulcerative lesion altogether, compared with 35% on acyclovir alone and 26% on placebo.6Journal of the American Academy of Dermatology. Early treatment of cold sores with topical ME-609 decreases the frequency of ulcerative lesions: A randomized, double-blind, placebo-controlled, patient-initiated clinical trial The cumulative lesion area was cut in half relative to placebo. A UV-exposure study similarly found that the combination reduced classical lesion development by about 29% compared with placebo.7PubMed Central. Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialis
The catch is cost. Xerese is typically much more expensive than plain acyclovir cream and is not always covered by insurance. For people whose outbreaks regularly progress to full blistering despite early treatment with a standard antiviral, though, the combination approach can make a noticeable difference in how bad the sore gets.
Why Timing Makes or Breaks Topical Treatment
Every topical herpes cream works better the earlier you apply it. This is not just a marketing nudge on the box. The virus replicates fastest in the first hours of an outbreak, during what people often describe as the tingling or prodrome stage. Once blisters have formed and the virus has already spread through a patch of skin cells, a cream applied to the surface can only limit further damage rather than undo what has already happened.
In the large acyclovir cream trials, the benefit held whether people started treatment early (during the tingling or redness stage) or later (once papules or vesicles had appeared), but the magnitude of improvement was greater with early initiation.1PubMed Central. Acyclovir Cream for Treatment of Herpes Simplex Labialis: Results of Two Randomized, Double-Blind, Vehicle-Controlled, Multicenter Clinical Trials For the combination acyclovir-hydrocortisone cream, early application was specifically linked to the prevention of ulcerative lesions. In practical terms, keeping a tube in your bag or nightstand so you can apply it the moment you feel that familiar tingle is probably the single most important thing you can do to get the most out of any topical treatment.
Topical Creams for Genital Herpes
Most topical antiviral creams are approved and marketed for oral herpes (cold sores), and that is where the bulk of the research sits. But acyclovir cream has been studied for genital herpes too. In controlled trials, topical acyclovir cream applied to genital lesions significantly reduced viral shedding, new lesion formation, time to healing, and symptom duration for both first episodes and recurrences.8Journal of Antimicrobial Chemotherapy. Topical acyclovir in the treatment of genital herpes: a comparison with systemic therapy That same research noted the cream compared quite favorably with systemic (oral) acyclovir treatment, especially for recurrent episodes.
Despite those findings, current medical practice overwhelmingly favors oral antiviral pills (acyclovir, valacyclovir, or famciclovir) over creams for genital herpes. The reasoning is that oral drugs achieve higher and more consistent drug levels in genital tissue than a cream can, and compliance is simpler with a pill taken a few times a day than a cream applied to hard-to-reach areas multiple times daily. A review of treatment recommendations acknowledged that better topical options for genital herpes are still needed.9PubMed. Current recommendations for the treatment of genital herpes If you have genital herpes, a doctor will almost certainly prescribe oral antivirals as the primary treatment; topical cream might be used as a supplement, but it is not the standard first choice.
Can Topical Creams Prevent Outbreaks?
People who get frequent cold sores naturally wonder whether they could just apply antiviral cream daily to keep outbreaks from starting. The evidence here is discouraging. A Cochrane systematic review found no evidence that short-term use of topical antiviral agents prevented recurrent cold sores. Two trials of topical acyclovir 5% cream showed it probably has little effect on preventing recurrence, and a trial of topical foscarnet 3% cream similarly showed no meaningful prevention benefit.10Cochrane Database of Systematic Reviews. Interventions for prevention of herpes simplex labialis (cold sores on the lips) One trial of long-term acyclovir cream use found fewer clinician-diagnosed recurrences during the treatment period, but patients themselves did not report fewer outbreaks, making the practical benefit unclear.
If prevention is your goal, oral antiviral suppression therapy (usually daily valacyclovir) is the route with the strongest evidence. Topical creams are treatment tools, not prevention tools.
Zinc, Lemon Balm, and Other Non-Prescription Topicals
Several non-antiviral topical treatments have some research behind them, though none has the depth of evidence supporting acyclovir or penciclovir.
Zinc preparations have attracted the most interest. A randomized trial found that a zinc oxide/glycine cream shortened cold sore duration to an average of five days, compared with six and a half days for placebo, when applied within 24 hours of symptom onset. The cream also reduced blistering, soreness, itching, and tingling.11PubMed. A randomized clinical trial on the treatment of oral herpes with topical zinc oxide/glycine A separate small study of a 4% zinc sulfate solution applied to recurrent herpes skin infections reported that pain, tingling, and burning stopped completely within 24 hours in all 18 patients treated, and crusting occurred within one to three days with no adverse effects.12Acta Dermato-Venereologica. Topical application of zinc-solutions: a new treatment for herpes simplex infections of the skin? Zinc is generally safe and inexpensive, making it a reasonable option if you want to try something alongside or instead of an antiviral, though the evidence base is thinner.
Lemon balm (Melissa officinalis) essential oil has shown strong antiviral activity against both HSV-1 and HSV-2 in laboratory studies, reducing viral plaque formation by over 97% at noncytotoxic concentrations. The oil appears to work before the virus enters cells, and its lipophilic nature helps it penetrate skin.13PubMed. Melissa officinalis oil affects infectivity of enveloped herpesviruses Lab results do not automatically translate to clinical effectiveness, though, and large randomized human trials of lemon balm cream for herpes are still lacking. If you want to experiment with lemon balm lip balms or creams, the risk is low, but managing expectations is wise.
Hydrocolloid Patches as an Alternative Delivery
Hydrocolloid cold sore patches (like Compeed) represent a different approach entirely. Rather than delivering an antiviral drug, they create a moist wound-healing environment over the sore, protect it from contamination and mechanical irritation, and are cosmetically discreet. A randomized study compared hydrocolloid patches to acyclovir 5% cream and found comparable outcomes in terms of healing time and symptom relief.14PubMed. Randomized clinical study comparing Compeed cold sore patch to acyclovir cream 5% in the treatment of herpes simplex labialis Some people find patches easier to use than cream, especially during the day when they want to conceal the lesion. You can also apply a topical antiviral underneath certain patches, getting both the drug delivery and the protective barrier.
Safety and Side Effects of Topical Antivirals
Topical antiviral creams are generally well tolerated. The most common side effects are mild and local: slight stinging, dryness, or peeling at the application site. Serious reactions are rare, but allergic contact dermatitis has been documented. A case series described two patients who developed allergic reactions after prolonged use of acyclovir cream, confirmed by patch testing. In both cases the allergy was to the acyclovir itself rather than to the inactive ingredients in the cream base.15PubMed. Allergic Contact Dermatitis from Topical Acyclovir: Case Series If a cold sore seems to be getting worse despite cream application, or if you develop increasing redness and irritation spreading beyond the sore, it is worth considering that the cream itself could be part of the problem.
The long-term safety profile of acyclovir as a compound is well established after decades of use. It has been approved for use in children and monitored in over 1,000 pregnancies.16Oxford Academic (The Journal of Infectious Diseases). Valacyclovir for Herpes Simplex Virus Infection: Long-Term Safety and Sustained Efficacy after 20 Years’ Experience with Acyclovir For the topical cream specifically, systemic absorption is minimal, meaning very little of the drug gets into your bloodstream. This makes the cream a lower-risk option than oral antivirals for people who want to avoid systemic medication, though it also means less drug reaches deep tissue.
Approved Uses Versus Off-Label Uses
Herpes creams exist in a complicated regulatory landscape. Acyclovir, penciclovir, famciclovir, and valacyclovir are the four main antivirals licensed for herpes simplex management, but their approved indications cover only a handful of specific scenarios. A review of the Canadian regulatory landscape found that these drugs are approved for just four orolabial and anogenital indications in healthy people, yet their efficacy and safety have been demonstrated in controlled trials for 13 additional off-label uses.17PubMed Central. Contemporary antiviral drug regimens for the prevention and treatment of orolabial and anogenital herpes simplex virus infection in the normal host: Four approved indications and 13 off-label uses Availability also varies by country: acyclovir cream is sold over the counter in some nations but requires a prescription in others. Docosanol is OTC in the U.S. and Canada but may not be available at all elsewhere. If you’re traveling or living abroad, the cream you’re used to may not be on the pharmacy shelf.
When Standard Creams Do Not Work
For most healthy people, the creams discussed above will shorten an outbreak modestly and reduce discomfort. But certain populations face a harder situation. People with weakened immune systems, whether from HIV, organ transplantation, chemotherapy, or other causes, can develop herpes outbreaks that are more severe, longer-lasting, and sometimes resistant to standard antivirals like acyclovir. Resistance typically arises through mutations in the viral enzyme that acyclovir depends on to become active.
For these acyclovir-resistant infections, treatment options become more limited and usually require intravenous drugs like foscarnet, which carry more side effects. However, topical imiquimod, an immune-modulating cream normally used for genital warts, has shown promise as an alternative. A case series documented three immunocompromised patients with presumed acyclovir-resistant genital herpes who were successfully treated with topical imiquimod.18Sexually Transmitted Infections (BMJ). Topical imiquimod treatment of aciclovir-resistant herpes simplex disease: case series and literature review Imiquimod does not attack the virus directly; it stimulates the local immune response to fight the infection. It is not a first-line treatment for herpes in anyone, but for people who have run out of conventional options, it represents an important backup.
Experimental Topical Approaches
Researchers continue working on better ways to get antiviral drugs through the skin. One of the limitations of current creams is that acyclovir does not penetrate skin very well on its own, so a lot of the drug you smear on sits on the surface rather than reaching the deeper layers where the virus is replicating. Solid lipid nanoparticle formulations are one experimental solution. A study testing acyclovir loaded into these nanoparticles found over 15-fold greater accumulation of the drug in dermal tissue compared with commercially available acyclovir cream after 24 hours.19PubMed Central. Enhanced dermal delivery of acyclovir using solid lipid nanoparticles These formulations are not yet available commercially, but they hint at a future where topical treatment could be substantially more effective than what current creams deliver.
Another experimental direction involves immune-modulating topical gels. Resiquimod, a compound that activates local immune defenses, was tested as a 0.01% gel for genital HSV-2. The gel reduced both lesion rates and viral shedding rates compared with placebo, with the effect growing stronger over the study period: by the final sampling window, the lesion rate was 3% in the resiquimod group versus 22% in the placebo group.20Oxford Academic (The Journal of Infectious Diseases). Topical Resiquimod 0.01% Gel Decreases Herpes Simplex Virus Type 2 Genital Shedding: A Randomized, Controlled Trial Unlike antiviral creams that fight an active outbreak, immune-modulating topicals aim to keep the virus in check before it surfaces. If these approaches prove effective in larger trials, they could eventually fill the gap where current creams fall short, particularly in reducing transmission and preventing recurrences rather than just treating existing sores.
Managing Pain During an Outbreak
Antiviral creams target the virus, but they are not painkillers. For the burning and stinging that accompany a herpes outbreak, many people layer on additional topical treatments. Over-the-counter numbing agents containing benzocaine or lidocaine can take the edge off. A small clinical study tested a topical local anesthetic applied three times over 16 hours to cold sores and found that about 40% of patients had complete remission of symptoms within 24 hours of the last application.21Wiley Online Library / PubMed Central. Local anesthetic improves individuals affected with herpes simplex type 1 labialis That study was small, and the result should be interpreted cautiously, but it reinforces what many people already discover on their own: a numbing cream or gel applied between antiviral cream applications can make the wait for healing considerably more bearable. Just be careful not to apply so many products that you irritate the already-damaged skin, and wash your hands thoroughly after every application to avoid spreading the virus to your eyes or other areas.